🔎 Trials Near Me

Gara Jalqabaatti › Glioma › New York › New York City

Qorannoo klinikaalii Glioma New York City, NY keessatti

Qorannoo 25 Glioma f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, New York
  • Research Site, New York
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05417594

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Namoota walitti qabaa jiraSadarkaa 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
12 Months – 21 Years · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Namoota walitti qabaa jiraSadarkaa 2
  • Columbia University Irving Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07326566

A Study of Mirdametinib in People With Central Nervous System Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07539441

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT05489783

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center, New York
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Namoota walitti qabaa jiraSadarkaa 1
  • New York University, New York
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04485559

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Namoota walitti qabaa jiraSadarkaa 4
  • New York Presbyterian Hospital-Columbia University Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07486713

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Namoota walitti qabaa jiraSadarkaa 1
  • NYU Langone Health, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07464925

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Namoota walitti qabaa jiraSadarkaa 2
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT05188508

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

Namoota walitti qabaa jira
  • NYU Langone Health, New York
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT06910306

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT06712875

Chronic CED of TPT for Recurrent Malignant Glioma

Namoota walitti qabaa jiraSadarkaa 1
  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT06666712

A Study of 177Lu-PSMA-617 in People With Gliomas

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT07223034

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Namoota walitti qabaa jiraSadarkaa 3
  • Lenox Hill Brain Tumor Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Wax-2026 · NCT05271240

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Namoota walitti qabaa jira
  • Lenox Hill Brain Tumor Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Wax-2026 · NCT05954858

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Namoota walitti qabaa jira
  • Lenox Hill Brain Tumor Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Wax-2026 · NCT05979064

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Columbia University Medical Center, New York
  • Memorial Slone Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT06326411

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06126744

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Namoota walitti qabaa jiraSadarkaa 1/2
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06810544

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Namoota walitti qabaa jiraSadarkaa 2
  • Lenox Hill Brain Tumor Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT02800486

FUS Etoposide for DMG

Namoota walitti qabaa jiraSadarkaa 1
  • Columbia University Irving Medical Center, New York
Umuriin 4 hanga 21 · Saalaa hunda · Haaromfame 28-Ama-2026 · NCT05762419

Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • NYU Langone Health, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ama-2026 · NCT06829173

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

Namoota walitti qabaa jira
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Onk-2025 · NCT00870129

Qorannoo Glioma magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.